Virtual Summit Series
September 9th & 10th
12:00PM – 1:30PM EDT
September Virtual Summit Series
Join fellow colleagues and pharmaceutical marketers, researchers, and thought leaders for a live, virtual innovation Summit hosted by the Digital Health Coalition (DHC) and Otsuka.
The summit will kick off the fall with two information filled sessions on September 9th & 10th, from 12:00pm – 1:30pm EST. Content will be shared via presenters and panelists in an interactive virtual format. Content will be recorded, however some sessions will only be available live.
Featured Content Experts
Behavioral Health Strategist
Solome is a behavioral health strategist passionate about frontier technologies and solutions transforming mental health, equity and access. She works with PE funds, foundations, chronic disease companies, mental health startups, pharma, health plans and systems as a behavioral health technology subject matter expert. Solome’s work has spanned behavioral health and human service consulting, venture capital, corporate development and various operating roles at behavioral health software companies large and small. Solome founded and ran a mental health tech startup and, as a former anxious teen, founded and ran the non-profit AnxietyInTeens.org for ten years.
VP and Head of Global Digital Strategy
Candace Saldarini, M.D.
Sr. Director, Applied Innovation Process Improvement
SVP, Research and Development
Senior Director, Digital Therapeutics Commercial Lead
SVP Clinical Development, CNS
Head of Digital Portfolio Strategy
September 9: 12:00 – 1:30PM EDT
Shwen Gwee, VP and Head of Global Digital Strategy, BMS
Edouard Gasser, CEO and Founder, Tilak Healthcare
- Monique Levy, Chief Commercial and Strategy Officer, Woebot Health
- Dave Mihalovic, EVP, Juice Pharma
- Chris Martini, Chief Provider Officer, PatientPoint
- Mark Bard, co-founder, DHC Group
Rohit Bansal, Senior Director, Digital Therapeutics Commercial Lead, Otsuka
Shaheen Lakhan, SVP, Research and Development, Click Therapeutics
- Mark Bard, Co-Founder, DHC Group
- Rohit Bansal, Senior Director, Digital Therapeutics Commercial Lead, Otsuka
September 10: 12:00 – 1:30PM EDT
Candace Saldarini, M.D., Sr. Director, Applied Innovation Process Improvement, Otsuka Pharmaceuticals
Solome Tibebu, Behavioral Health Strategist
Solome Tibebu is passionate about frontier technologies and solutions transforming mental health, equity and access. She works with PE funds, foundations, chronic disease companies, mental health startups, pharma, health plans and systems as a behavioral health technology subject matter expert.
Alexandria Wise, PhD, SVP Clinical Development, CNS, Syneos Health
Keri McDonough, VP, Head of Patient Voice Consortium, Syneos Health
Digital and technological advances have led to a tremendous opportunity to drive accessibility, diversity and participation through virtual and decentralized forums. But not all patients can access equally; bandwidth, location, privacy, age and other factors can be exclusionary and cause an unintended divide. In mental health, patient perceptions and privacy concerns can lead to an even greater divide — but also greater opportunity to provide flexibility and options that align with patient needs. Looking at patient interactions with technology, clinical trials and HCPs, we can think differently about the future of digital medicine in mental health and overall while keeping patient needs in focus.
Mark Bard, Co-Founder, DHC Group
Spencer Curtis, Head of Digital Portfolio Strategy, Otsuka